Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

European Notebook: IPO Fever Comes To Europe; EMA Plans Adaptive Licensing Pilot Project

Executive Summary

Pharmaceutical and biotech companies in Europe take heart from IPOs and new governmental schemes to improve patients’ early access to innovative medicines, while fresh calls are made for an integrated, over-arching European industrial strategy for the life sciences sector.

Advertisement

Related Content

EFPIA Calls For Increased EU Collaboration Ahead Of European Elections
EMA Looks At Avastin, As Novartis/Roche Appeal Italian Competition Fines
Track-And-Trace: With Deadline A Year Away, Some Lessons From Early Adopters
AZ Restructures, But Will Changes Sideline Plans To Accelerate R&D?

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS056006

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel